Growth Metrics

Solid Biosciences (SLDB) Other Accumulated Expenses: 2017-2024

Historic Other Accumulated Expenses for Solid Biosciences (SLDB) over the last 4 years, with Mar 2024 value amounting to $92,000.

  • Solid Biosciences' Other Accumulated Expenses rose 67.27% to $92,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $92,000, marking a year-over-year increase of 67.27%. This contributed to the annual value of $24,000 for FY2023, which is 71.43% up from last year.
  • According to the latest figures from Q1 2024, Solid Biosciences' Other Accumulated Expenses is $92,000, which was up 283.33% from $24,000 recorded in Q4 2023.
  • In the past 5 years, Solid Biosciences' Other Accumulated Expenses ranged from a high of $162,000 in Q3 2023 and a low of $14,000 during Q4 2022.
  • In the last 3 years, Solid Biosciences' Other Accumulated Expenses had a median value of $85,000 in 2022 and averaged $80,222.
  • Within the past 5 years, the most significant YoY rise in Solid Biosciences' Other Accumulated Expenses was 408.70% (2023), while the steepest drop was 63.33% (2023).
  • Quarterly analysis of 4 years shows Solid Biosciences' Other Accumulated Expenses stood at $35,000 in 2021, then crashed by 60.00% to $14,000 in 2022, then surged by 71.43% to $24,000 in 2023, then spiked by 67.27% to $92,000 in 2024.
  • Its last three reported values are $92,000 in Q1 2024, $24,000 for Q4 2023, and $162,000 during Q3 2023.